A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia
Clinical trial NCT06916793 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06916793
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-30
- Primary completion
- 2026-12-19
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.